“40% of generic drugs have just one manufacturer”
That is part due to the squeeze on generic drug pricing from group purchasing organizations and others. This 60 Minutes report is interesting.
Unbiased Analysis of Today's Healthcare Issues
That is part due to the squeeze on generic drug pricing from group purchasing organizations and others. This 60 Minutes report is interesting.
Perhaps the answer is yes, if we want to have a more resilient supply chain. At least that is the argument from a commentary by Mattingly and Conti (2022): Several medications that patients need have been in short supply before and during the COVID-19 pandemic, including low-priced, off-patent generic drugs. The White House recently released…
I previously covered research from Dickson and Kent (2021) that examined how the entry of generic drugs impacts the price Medicare pays. In that study, the authors found that “the presence of 1 generic competitor was associated with a 14.9% mean price reduction in the bundled ASP, 2 generic competitors were associated with a 32.7%…